Booster shot increases efficacy to 95.6% against Covid-19 when Delta was the prevalent strain.

#PFEcolleague

Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine | Business Wire businesswire.com/news/home/2021…